678 related articles for article (PubMed ID: 33256131)
21. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma].
Tian L; Zhang C; Liu W; Wang X; Zheng W; Xie Y; Lin N; Ying Z; Ping L; Deng L; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):759-62. PubMed ID: 24844960
[TBL] [Abstract][Full Text] [Related]
23. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
24. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J; Paszkiewicz-Kozik E; Michalski W; Rymkiewicz G; Szpila T; Butrym A; Giza A; Zaucha JM; Kalinka-Warzocha E; Wieczorkiewicz A; Zimowska-Curyło D; Knopińska-Posłuszny W; Tyczyńska A; Romejko-Jarosińska J; Dąbrowska-Iwanicka A; Gruszecka B; Jamrozek-Jedlińska M; Borawska A; Hołda W; Porowska A; Romanowicz A; Hellmann A; Stella-Hołowiecka B; Deptała A; Jurczak W
Br J Haematol; 2020 Mar; 188(6):898-906. PubMed ID: 31792945
[TBL] [Abstract][Full Text] [Related]
25. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
26. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
27. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and Treatment of Gastric Mucosa-associated Lymphoid Tissue Lymphoma].
Gong EJ; Choi KD
Korean J Gastroenterol; 2019 Dec; 74(6):304-313. PubMed ID: 31870136
[TBL] [Abstract][Full Text] [Related]
29. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
31. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
32. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
33. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
35. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
Zucca E; Bertoni F
Blood; 2016 Apr; 127(17):2082-92. PubMed ID: 26989205
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
39. Clinical aspects and therapy of gastrointestinal MALT lymphoma.
Thieblemont C; Zucca E
Best Pract Res Clin Haematol; 2017; 30(1-2):109-117. PubMed ID: 28288705
[TBL] [Abstract][Full Text] [Related]
40. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]